Last updateSat, 09 Dec 2023 12pm

Excelitas Technologies to Acquire Heraeus Noblelight Business from Heraeus Group

Excelitas Moves to Further Expand and Broaden its Industrial Technology Portfolio with a Highly Complementary Set of Photonic Solutions across the Lighting Spectrum

Excelitas TechnologiesÒ Corp., a leading industrial and medical technology manufacturer focused on delivering innovative, market-driven photonic solutions, announced that it has signed a definitive agreement with Heraeus Group (Hanau, Germany) to acquire the Heraeus Noblelight business with approximately 850 employees, including operations in Germany, United Kingdom, United States, China and Japan, along with several key application centers.
Heraeus Noblelight is an operative company within Heraeus Group, a broadly diversified and globally leading family-owned technology group. Heraeus Noblelight specializes in the development and manufacture of specialty light sources and solutions, from ultraviolet to infrared, used within analytical instrumentation, industrial curing, water treatment, electronics manufacturing, medical and cosmetic therapy, battery production and many others.
"We see tremendous potential in the union of Heraeus Noblelight’s technology portfolio with our own extensive offering in plasma and LED products. Leveraging our combined investments and expanded offering will drive growth and present innovative integrated solutions to our highly complementary customer and product mix across a variety of unique markets,” said Michael Ersoni, Excelitas Technologies EVP Commercial Business.
The acquisition of Heraeus Noblelight will represent the latest in a series of strategic acquisitions by Excelitas Technologies since its establishment in 2010.
"As a leading player in the specialty light market, Heraeus Noblelight has a strong footprint in the areas of market access, problem-solving expertise, and technological bandwidth. We are convinced, that this agreement will further boost Heraeus Noblelight’s stable growth path of the last years,” said Jan Rinnert, CEO and Chairman of the Board of Managing Directors of Heraeus Group.
The agreement has been approved by both companies. Terms are not being disclosed and the transaction is expected to close before the end of 2023 (subject to obtaining regulatory approvals).


  • Latest Post

  • Most Read

  • Twitter

Who's Online

We have 9545 guests and no members online

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.